Stock Events

Stock Events

Castle Biosciences 

$24.6
43
-$0.92-3.61% Tuesday 20:00

Statistics

Day High
25.43
Day Low
24.43
52W High
43.04
52W Low
14.65
Volume
384,511
Avg. Volume
-
Mkt Cap
718.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.9
-0.49
-0.09
0.32
Expected EPS
-0.49
Actual EPS
N/A

Financials

5.49%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
664.14MRevenue
36.49MNet Income

Analyst Ratings

46.6Average Price Target
The highest estimate is 52.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CSTL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health specializes in liquid biopsy tests for cancer, which competes with Castle's cancer diagnostic tests.
Myriad Genetics
MYGN
Mkt Cap466.55M
Myriad Genetics offers genetic testing and precision medicine, similar to Castle's approach in providing diagnostics for cancer.
Fulgent Genetics
FLGT
Mkt Cap407.57M
Fulgent Genetics focuses on genetic testing across various conditions, including cancer, competing in the diagnostics space.
Qiagen NV
QGEN
Mkt Cap7.06B
Qiagen is known for sample and assay technologies for molecular diagnostics, competing in the cancer diagnostics market.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences provides sequencing systems that can be used in cancer research and diagnostics, indirectly competing with Castle.
Illumina
ILMN
Mkt Cap20.63B
Illumina offers sequencing and array-based solutions for genetic analysis, which are crucial in cancer diagnostics and research, competing with Castle's approach.

About

There is no Profile data available for 086.F.
Show more...
CEO
Mr. Derek J. Maetzold
Employees
784
Country
United States
ISIN
US14843C1053

Listings

F
DE
086.F
XNAS
US
CSTL
BOATS
BOATS
CSTL.BOATS

0 Comments

Share your thoughts

FAQ

What is Castle Biosciences stock price today?▼
The current price of CSTL is $24.6 USD — it has decreased by -3.61% in the past 24 hours. Watch Castle Biosciences stock price performance more closely on the chart.
What is Castle Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Castle Biosciences stocks are traded under the ticker CSTL.
Is Castle Biosciences stock price growing?▼
CSTL stock has risen by +1.49% compared to the previous week, the month change is a -0.53% fall, over the last year Castle Biosciences has showed a +48.01% increase.
What is Castle Biosciences market cap?▼
Today Castle Biosciences has the market capitalization of 718.05M
What is Castle Biosciences revenue for the last year?▼
Castle Biosciences revenue for the last year amounts to 664.14M USD.
What is Castle Biosciences net income for the last year?▼
CSTL net income for the last year is 36.49M USD.
How many employees does Castle Biosciences have?▼
As of May 06, 2026, the company has 784 employees.
In which sector is Castle Biosciences located?▼
Castle Biosciences operates in the Health & Wellness sector.
When did Castle Biosciences complete a stock split?▼
Castle Biosciences has not had any recent stock splits.
Where is Castle Biosciences headquartered?▼
Castle Biosciences is headquartered in Friendswood, United States.